Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.
about
Biomarkers and Targeted Therapy in Pancreatic CancerPrognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysisFunctional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.Modeling Combined Chemotherapy and Particle Therapy for Locally Advanced Pancreatic Cancer
P2860
Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase II Trial of Cetuximab an ...... ue Sampling Feasibility Study.
@en
Phase II Trial of Cetuximab an ...... ue Sampling Feasibility Study.
@nl
type
label
Phase II Trial of Cetuximab an ...... ue Sampling Feasibility Study.
@en
Phase II Trial of Cetuximab an ...... ue Sampling Feasibility Study.
@nl
prefLabel
Phase II Trial of Cetuximab an ...... ue Sampling Feasibility Study.
@en
Phase II Trial of Cetuximab an ...... ue Sampling Feasibility Study.
@nl
P2093
P2860
P50
P921
P356
P1476
Phase II Trial of Cetuximab an ...... ue Sampling Feasibility Study.
@en
P2093
Adrian Crellin
Angel Garcia-Alonso
Azeem Saleem
Ganesh Radhakrishna
Gillian R Santorelli
James Cullen
M Ben Taylor
Patricia M Price
Pooja Jain
Ric Swindell
P2860
P356
10.1593/TLO.13724
P577
2014-02-01T00:00:00Z